Statement Of Changes In Equity [Abstract]

Ascelia Pharma - Filing #678716

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	74 328 SEK	—	639 962 SEK	—	—	- SEK	—	—	34 871 SEK	671,000 SEK	74 328 SEK	—	678 747 SEK	180 859 SEK	—	—	—	—	- SEK	533 732 SEK	34 871 SEK	972,000 SEK	180 859 SEK	678 747 SEK	—	—	—	405 827 SEK	678 831 SEK	307 834 SEK	307 834 SEK	- SEK	254,000 SEK	34 576 SEK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	109 288 SEK	—	109 288 SEK	—	- SEK	109 288 SEK	—	- SEK	- SEK	—	—	—	- SEK	—	—	- SEK	131 223 SEK	131 223 SEK	- SEK	—	—	—	—	—	—	131 223 SEK	- SEK	- SEK	—	—	—	—	—	—	—
Other comprehensive income	301,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	718,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Comprehensive income	109 589 SEK	—	109 589 SEK	—	- SEK	109 288 SEK	—	301,000 SEK	- SEK	—	—	—	- SEK	—	—	- SEK	130 504 SEK	131 223 SEK	- SEK	—	—	—	—	—	—	130 504 SEK	718,000 SEK	- SEK	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	3 088 SEK	—	3 088 SEK	—	- SEK	3 088 SEK	—	- SEK	- SEK	—	—	—	- SEK	—	—	- SEK	3 612 SEK	3 612 SEK	- SEK	—	—	—	—	—	—	3 612 SEK	- SEK	- SEK	—	—	—	—	—	—	—